Renal Cell Cancer Update

Dr Amy DeZern from The Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, discusses recent therapeutic advances in higher-risk myelodysplastic syndromes. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHigherRiskMDS22).

Dr Rachna Shroff from the University of Arizona Cancer Center in Tucson, Arizona, discusses data and the practical implications from key gastrointestinal cancer presentations made at recent major oncology conferences. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayGI22).

Dr Rebecca Heist from Massachusetts General Hospital Cancer Center in Boston, Massachusetts discusses recent therapeutic advances in the management of MET-altered non-small cell lung cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMETAlteredNSCLC22).

Dr Brady Stein from Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses recent therapeutic advances in myelofibrosis. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMF22).

Dr Pamela Kunz from the Yale Cancer Center in Palo Alto, California, discusses recent therapeutic advances in neuroendocrine tumors. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNeuroendocrine22).

Professor Axel Hauschild from Kiel University in Kiel, Germany, discusses recent therapeutic advances in the treatment of metastatic melanoma with BRAF mutations. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayBRAFMelanoma22).

Dr Justin Gainor from Massachusetts General Hospital in Boston, Massachusetts, discusses recent therapeutic advances in non-small cell lung cancer with RET fusions. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayRETNSCLC22).

Professor Sia Daneshmand from the USC/Norris Comprehensive Cancer Center in Los Angeles, California, discusses recent advances in and perspectives on the management of nonmetastatic urothelial bladder cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNonmetastaticBladder22).

Dr Benjamin Levy from the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses recent therapeutic advances in the care of patients with small cell lung cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodaySCLC22).

Dr Amrita Krishnan from City of Hope in Duarte, California, discusses recent therapeutic advances in BCMA-directed therapies for multiple myeloma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayBCMAMM22).

Dr Heather Wakelee from Stanford Cancer Institute in Palo Alto, California, discusses the management of localized non-small cell lung cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayLocalizedNSCLC22).

Dr Stephen Ansell from the Mayo Clinic in Rochester, Minnesota, reviews the evolution of the Hodgkin lymphoma treatment landscape. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22HL).

Dr Charles Powell from the Mount Sinai National Jewish Health Respiratory Institute in New York discusses the diagnosis and treatment of interstitial lung disease in patients receiving anticancer therapy. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22ILD).

Dr Mansoor Raza Mirza from Copenhagen University Hospital in Copenhagen, Denmark, discusses recent therapeutic advances in the care of patients with endometrial cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22Endometrial).

Dr Asim Farooq from The University of Chicago Medical Center in Chicago, Illinois, discusses common ocular toxicities associated with anticancer agents, including antibody-drug conjugates and EGFR, ALK, MEK and BRAF inhibitors. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22OcularToxicities).

Dr Joshua Sabari from the Perlmutter Cancer Center in New York discusses key presentations in lung cancer from the 2022 ASCO annual meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOLung22).

Dr Alexander Spira of the Virginia Cancer Specialists Research Program in Fairfax, Virginia, discusses recent therapeutic advances in the care of patients with non-small cell lung cancer with KRAS mutations. CME information and select publications here (http://www.researchtopractice.com/OncologyToday22KRASMutantNSCLC).

Dr Brian Slomovitz from the Mount Sinai Medical Center in Miami, Florida, discusses key abstracts in gynecologic cancers presented at the 2022 ASCO annual meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOGyn22).

Dr Ezra Cohen from the Moores Cancer Center at UC San Diego Health in La Jolla, California, discusses key abstracts presented in head, neck and thyroid cancers at the 2022 ASCO annual meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOHN22).

Dr Shanu Modi from Memorial Sloan Kettering Cancer Center in New York discusses recent therapeutic advances in HER2-low breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2Low2/22).